INLIF LIMITED Notified by Nasdaq of Bid Price Deficiency

Quanzhou, China, Oct. 30, 2025 – INLIF LIMITED (Nasdaq: INLF), which specializes in the research, development, manufacturing, and sales of manipulator arms designed for injection molding machines (referred to as “the Company” or “INLIF”), announced today that it received a deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) on October 27, 2025. The Notice informed the Company that, based on the closing bid price of its Class A Ordinary Shares (“Shares”) over a continuous 30-business-day period from September 11, 2025, to October 24, 2025, INLIF is not in compliance with Nasdaq Listing Rule 5550(a)(2), which mandates a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market (the “Minimum Bid Price Requirement”). The Company is issuing this press release as per Nasdaq Listing Rule 5810(b) and the instructions provided in the Notice.

This Notice does not immediately impact the continued listing status of the Shares on The Nasdaq Capital Market. The Company has been granted a compliance period of 180 calendar days from the date of the Notice, extending until April 27, 2026, to regain compliance, in accordance with Nasdaq Listing Rule 5810(c)(3)(A). Should the closing bid price of the Shares meet or exceed $1.00 per share for at least 10 consecutive business days at any point before April 27, 2026, the Staff will issue a written confirmation that the Company has satisfied the Minimum Bid Price Requirement, thereby resolving the issue.

If the Company fails to regain compliance with the Minimum Bid Price Requirement within the initial 180-calendar-day period, it may be eligible for an extension of the compliance period.

To qualify for such an extension, pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(ii), the Company would need to satisfy the continued listing requirement for the market value of publicly held shares, along with all other initial listing standards for The Nasdaq Capital Market, excluding the bid price requirement. It would also be required to submit written notification of its intent to remedy the deficiency during the second compliance period, potentially through a reverse stock split, if necessary. If these conditions are met, Nasdaq will inform the Company that it has been granted an additional 180 calendar days. However, if the Staff determines that the Company is unlikely to resolve the deficiency, or if the Company is otherwise ineligible, Nasdaq will issue a notice indicating that its securities will face delisting. At that juncture, the Company would have the right to appeal the delisting decision to a Hearings Panel.

The Company’s business operations are not affected by the receipt of this Notice. INLIF intends to proactively monitor the closing bid price of its Shares and assess available strategies to regain compliance with the Minimum Bid Price Requirement. Nevertheless, there is no assurance that the Company will be able to regain or maintain compliance with this requirement. Furthermore, should the Company opt to request an additional 180-day compliance period, there is no guarantee that Nasdaq will approve such a request.

About INLIF LIMITED

INLIF, through its operating entity in the People’s Republic of China, Ewatt Robot Equipment Co. Ltd., established in September 2016, is dedicated to the research, development, manufacturing, and sales of manipulator arms specifically designed for injection molding machines. The Company also provides installation and warranty services for these manipulator arms, as well as supplying related accessories and raw materials. INLIF offers a comprehensive range of self-developed injection molding machine-dedicated manipulator arms, including transverse single and double-axis, transverse and longitudinal multi-axis, and large bullhead multi-axis models. For additional information, please visit the Company’s website: .

Forward-Looking Statements

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Such statements encompass plans, objectives, goals, strategies, future events or performances, underlying assumptions, and other statements that are not merely historical facts. The Company employs forward-looking statements when using terms such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate,” or similar expressions that do not solely relate to past events. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from the Company’s expectations expressed in these statements. These statements are influenced by various uncertainties and risks, including but not limited to: the Company’s capacity to achieve its goals and strategies; its future business development and growth plans, including its financial condition and operational results; demand for and acceptance of its products and services; its reputation and brand; the impact of competition and pricing; technological changes; government regulations; import and export restrictions; fluctuations in general economic and business conditions; the Company’s ability to meet Nasdaq’s continued listing standards; assumptions underlying or related to any of the foregoing; and other risks detailed in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these and other reasons, investors are advised against placing undue reliance on any forward-looking statements in this press release. Further factors are elaborated in the Company’s SEC filings, including its current reports on Form 6-K and other submissions, all accessible for review at www.sec.gov. The Company disclaims any obligation to publicly update or revise these forward-looking statements to reflect events or circumstances occurring after the date hereof.

For investor and media inquiries, please contact:

INLIF LIMITED
Investor Relations Department
Email: 

Ascent Investor Relations LLC
Tina Xiao
Phone: +1 646-932-7242
Email: